OOIR: Observatory of International Research

Papers

(The H4-Index of Dermatology and Therapy is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Selectivity Profile of the Tyrosine Kinase 2 Inhibitor Deucravacitinib Compared with Janus Kinase 1/2/3 Inhibitors	67
Artificial Intelligence in Dermatology: Challenges and Perspectives	66
A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring	65
Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study	63
Menopause and the Skin: Old Favorites and New Innovations in Cosmeceuticals for Estrogen-Deficient Skin	52
Topical Probiotics in Dermatological Therapy and Skincare: A Concise Review	51
Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis	47
Gut–Brain–Skin Axis in Psoriasis: A Review	46
Rosacea and the Microbiome: A Systematic Review	46
Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options	43
Can COVID-19 Increase the Risk of Herpes Zoster? A Narrative Review	43
Unmet Medical Needs in the Treatment and Management of Generalized Pustular Psoriasis Flares: Evidence from a Survey of Corrona Registry Dermatologists	43
Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review	41
Rosacea Treatment: Review and Update	40
Urea in Dermatology: A Review of its Emollient, Moisturizing, Keratolytic, Skin Barrier Enhancing and Antimicrobial Properties	40
The Economic and Psychosocial Comorbidity Burden Among Adults with Moderate-to-Severe Atopic Dermatitis in Europe: Analysis of a Cross-Sectional Survey	40
Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities	38
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations	37
Psoriasis Prevalence and Severity by Expert Elicitation	36
Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis	36
Current and Emerging Strategies to Inhibit Type 2 Inflammation in Atopic Dermatitis	35
The Microbiome in Hidradenitis Suppurativa: A Review	34
Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial	33
Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review	32
Update on Melasma—Part II: Treatment	31

Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis	31
Risankizumab for the Treatment of Moderate-to-Severe Psoriasis: Real-Life Multicenter Experience from the Czech Republic	31
Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: Systematic Review and Network Meta-analysis	31
A Case of New-Onset Lichen Planus after COVID-19 Vaccination	28